Insight Molecular Diagnostics IMDX Balance Sheet (2015-2026)

NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Insight Molecular Diagnostics Quarterly Balance Sheet

Periods 46 quarters
Latest Jun 2026

Insight Molecular Diagnostics reported total assets of $29.44M and total liabilities of $50.74M for the quarter ended Jun 2026, down 41.7% year over year. This balance sheet covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
43.34M32.95M20.41M44.84M32.10M19.99M11.80M17.40M13.80M9.43M5.60M9.30M3.40M8.64M31.03M24.30M18.70M11.58M28.20M17.80M
Short-term InvestmentsInvestments (Current)
0.92M0.90M0.60M0.60M0.42M0.43M0.60M0.53M0.44M
Cash & Current Investments
44.26M33.85M21.01M45.44M32.52M20.43M12.40M17.93M14.24M9.43M5.60M9.30M3.40M8.64M31.03M24.30M18.70M11.58M28.20M17.80M
Receivables - NetNet Receivables
1.03M1.44M2.12M1.80M1.99M2.01M1.40M0.59M0.59M0.48M0.16M0.09M0.21M1.61M3.54M0.51M0.26M1.13M0.16M0.19M
Receivables
1.03M1.44M2.12M1.80M1.99M2.01M1.40M0.59M0.59M0.48M0.16M0.09M0.21M1.61M3.54M0.51M0.26M1.13M0.16M0.19M
Inventory
0.23M0.41M0.46M0.69M0.47M0.45M0.38M0.21M
Prepaid Assets
2.30M0.90M1.51M2.15M2.17M0.98M0.97M1.18M0.67M0.64M0.73M0.59M0.63M0.82M1.24M1.35M1.24M1.42M1.05M1.66M
Current Assets
47.59M39.14M24.62M49.37M36.64M25.54M15.65M20.98M16.92M10.70M6.54M9.97M4.79M11.76M36.26M26.84M21.39M15.31M30.52M20.54M
Non-Current Assets
Construction in Progress
0.28M1.24M3.06M2.86M2.35M2.14M0.73M0.52M0.71M0.73M0.32M0.36M0.30M0.34M0.36M0.26M0.69M0.77M0.47M0.26M
Property, Plant & Equipment (Net)PP&E (Net)
4.72M5.59M8.02M9.09M9.26M8.67M6.40M6.00M4.08M3.80M3.53M3.35M3.49M3.57M4.57M4.15M4.15M6.43M6.45M6.00M
Long-Term Investments
Goodwill
18.43M18.68M18.68M18.68M18.68M18.70M9.50M9.50M9.50M
Intangibles
92.72M61.72M90.32M89.34M88.36M61.63M56.59M56.64M56.62M56.59M56.57M56.55M56.53M14.61M14.60M14.60M14.60M
Goodwill & Intangibles
111.15M80.41M109.00M108.03M107.05M80.33M66.09M66.14M66.12M56.59M56.57M56.55M56.53M14.61M14.60M14.60M14.60M
Other Non-Current Assets
1.70M29.68M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.70M1.50M1.30M1.20M0.97M
Non-Current Assets
120.75M120.42M121.65M121.68M120.71M74.56M67.15M66.56M64.67M64.19M64.44M64.75M65.42M23.32M24.10M23.68M22.55M10.45M9.91M8.90M
Assets
168.34M159.56M146.27M171.05M157.34M100.09M82.80M87.54M81.59M74.89M70.97M74.72M70.22M35.08M60.36M50.52M43.94M25.76M40.43M29.44M
Liabilities
Current Liabilities
Accounts Payables
1.87M2.08M3.26M4.56M3.81M1.82M2.37M2.20M1.14M0.95M0.91M1.05M0.98M1.64M2.28M1.28M1.06M2.54M1.61M1.87M
Payables
1.87M2.08M3.26M4.56M3.81M1.82M2.37M2.20M1.14M0.95M0.91M1.05M0.98M1.64M2.28M1.28M1.06M2.54M1.61M1.87M
Accumulated Expenses
3.34M2.83M3.38M2.79M4.07M1.77M2.23M1.30M1.72M1.65M2.43M1.31M1.91M1.94M2.52M1.46M2.23M2.46M3.33M1.90M
Other Accumulated Expenses
2.02M1.12M1.12M1.12M1.12M1.12M1.12M1.12M1.12M1.12M2.78M2.74M1.98M
Short term Debt
1.50M1.31M0.94M0.57M
Current Leases
Total Current Liabilities
13.38M14.12M13.96M14.15M12.95M12.11M9.43M7.67M8.03M7.19M8.33M7.20M9.09M7.28M9.68M6.65M7.66M12.07M12.01M10.29M
Non-Current Liabilities
Capital Leases
Non-Current Debt
0.18M
Preferred Stock Liabilities
4.85M5.08M5.30M5.53M4.72M4.92M5.13M5.33M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
2.00M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
2.73M2.40M2.35M2.10M
Other Non-Current Liabilities
51.67M76.68M72.03M65.67M59.52M45.66M27.36M29.15M28.71M39.90M43.21M42.18M48.71M37.71M38.38M40.93M43.94M43.45M37.81M39.54M
Total Non-Current Liabilities
17.32M17.66M17.28M22.14M20.96M20.14M17.51M14.79M16.73M14.52M16.17M9.84M11.80M9.64M11.76M8.49M9.19M13.77M13.31M11.20M
Total Liabilities
68.99M94.35M89.31M87.81M80.49M65.80M44.87M43.94M45.44M54.42M59.38M52.02M60.51M47.35M50.14M49.42M53.13M57.22M51.12M50.74M
Shareholder's Equity
Total Debt
1.68M1.31M0.94M0.57M
Common Equity
99.35M65.22M56.97M83.24M76.86M34.29M37.93M43.60M36.14M20.47M11.59M22.70M9.71M-12.27M10.22M1.10M-9.20M-31.46M-10.69M-21.30M
Liabilities and Shareholders Equity
168.34M159.56M146.27M171.05M157.34M100.09M82.80M87.54M81.59M74.89M70.97M74.72M70.22M35.08M60.36M50.52M43.94M25.76M40.43M29.44M
Retained Earnings
-151.89M-187.77M-198.10M-206.44M-215.70M-260.68M-262.10M-262.10M-262.10M-289.88M-299.00M-303.54M-317.03M-350.54M-357.21M-367.00M-377.81M-400.76M-405.10M-416.31M

Insight Molecular Diagnostics Balance Sheet API

Pull Insight Molecular Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMDX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY